Logo image
Vascularized Brain Assembloids With Enhanced Cellular Complexity Provide Insights Into the Cellular Deficits of Tauopathy
Journal article   Peer reviewed

Vascularized Brain Assembloids With Enhanced Cellular Complexity Provide Insights Into the Cellular Deficits of Tauopathy

Xiaohuan Sun, Simeon Kofman, Victor C. Ogbolu, Celeste M. Karch, Larisa Ibric and Liang Qiang
Stem cells (Dayton, Ohio), v 42(2), pp 107-115
23 Nov 2023
PMID: 37995336
url
https://pmc.ncbi.nlm.nih.gov/articles/PMC10852025/pdf/sxad086.pdfView
Open

Abstract

Biotechnology & Applied Microbiology Cell & Tissue Engineering Life Sciences & Biomedicine Science & Technology Cell Biology Hematology Oncology
Advanced technologies have enabled the engineering of self-organized 3-dimensional (3D) cellular structures from human induced pluripotent stem cells (hiPSCs), namely organoids, which recapitulate some key features of tissue development and functions of the human central nervous system (CNS). While hiPSC-derived 3D CNS organoids hold promise in providing a human-specific platform for studying CNS development and diseases, most of them do not incorporate the full range of implicated cell types, including vascular cell components and microglia, limiting their ability to accurately recreate the CNS environment and their utility in the study of certain aspects of the disease. Here we have developed a novel approach, called vascularized brain assembloids, for constructing hiPSC-derived 3D CNS structures with a higher level of cellular complexity. This is achieved by integrating forebrain organoids with common myeloid progenitors and phenotypically stabilized human umbilical vein endothelial cells (VeraVecs), which can be cultured and expanded in serum-free conditions. Compared with organoids, these assembloids exhibited enhanced neuroepithelial proliferation, advanced astrocytic maturation, and increased synapse numbers. Strikingly, the assembloids derived from hiPSCs harboring the tauP301S mutation exhibited increased levels of total tau and phosphorylated tau, along with a higher proportion of rod-like microglia-like cells and enhanced astrocytic activation, when compared to the assembloids derived from isogenic hiPSCs. Additionally, the tauP301S assembloids showed an altered profile of neuroinflammatory cytokines. This innovative assembloid technology serves as a compelling proof-of-concept model, opening new avenues for unraveling the intricate complexities of the human brain and accelerating progress in the development of effective treatments for neurological disorders. Vascularized forebrain assembloids derived from the tauP301S mutant hiPSCs display elevated levels of total tau, phosphorylated tau, reactivated astrocytes, and distinctive pro-inflammatory cytokine profiles in contrast to their isogenic control counterparts. This innovative model holds significant promise for delving into the intricacies of the human brain and advancing our understanding of various neurological disorders.

Metrics

21 Record Views
6 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Biotechnology & Applied Microbiology
Cell & Tissue Engineering
Cell Biology
Hematology
Oncology
Logo image